TRIAL UPDATE: First patient was enrolled in the EORTC 1945
July 1, 2021
OligoRARE trial in oligometastatic rare cancers OligoRARE is an international study with 6 participating countries in Europe and a collaboration with the British Columbia Cancer Agency in Canada.
EORTC would like to thank The Anticancer Fund and Rising Tide Group for supporting this trial.
More info about the project here